ASCEND
BY NTHRYS

NTHRYSPhD AssistanceAi Radiopharmaceuticals

Ai Radiopharmaceuticals

Field
Category

Ai Radiopharmaceuticals

Select a category to explore research frontiers

Loading categories...

Research Frontiers in Secondary Malignancy Research

Research examines new cancers arising after radioactive treatment exposure. This risk is small and matters greatly for long surviving patients.

All AI Radiopharmaceuticals PhD categories